Month: June 2026

Home » Archives for June 2026

Tinlarebant NDA Submission Completed for Stargardt Disease Type 1, Targeting First Approved Therapy

Author(s)Ophthalmology Times Staff June 17, 2026 Fact checked by: Lucia Gambuzza Key Takeaways Belite’s rolling NDA for tinlarebant advances under Breakthrough Therapy Designation, with Fast Track,

Tinlarebant NDA Submission Completed for Stargardt Disease Type 1, Targeting First Approved Therapy Read More »

Accessibility Toolbar